Bharat Biotech vaccine approved for children above 12 years - The Sikh Times
Health & Wellness

Bharat Biotech vaccine approved for children above 12 years

04 Jan 21 Bharat Biotech’s anti-coronavirus vaccine ‘Covaxin’ has been approved for children above the age of 12 years by the Drugs Controller General of India (DCGI). Oxford-AstraZeneca coronavirus vaccine ‘Covishield’, manufactured by Pune-based Serum Institute of India (SII) has been approved for those above the age of 18. The DCGI had on Sunday approved Bharat Biotech’s ‘Covaxin’ and Serum’s ‘Covishield’ for emergency use in the country, paving the way for a massive inoculation drive.The permission to both the vaccines — Bharat Biotech’s Covaxin and Serum Institute’s ‘Covishield’ — has been granted for restricted use in emergency situations. Both the vaccines will be administered in two doses, the DCGi said in the permission letter.

Related posts

Chhattisgarh Asks Centre To Halt Covaxin- Harsh Vardhan’s

thesikh

Delhi’s Frontline Workers Get Vaccinated

thesikh

Inaugurated a mobile COVID-19 RT-PCR Lab at ICMR –Amit Shah

thesikh

Covid Vaccine Has Good Immune Response With Two-Dose Regime

thesikh

Serum Institute of India, the world’s biggest vaccine maker , hopeful of launching Covovax

thesikh

Massive fire at Serum Institute of India’s plant in Pune

thesikh

Leave a Comment